Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Impaired glucose tolerance (IGT) is a pre-diabetic state of increasing prevalence among obese adolescents. The purpose of this study was to determine the natural history of progression from normal glucose tolerance (NGT) to IGT in obese adolescents. RESEARCH DESIGN AND METHODS: We determined the evolution of beta-cell function, insulin sensitivity (S(I)), and glucose tolerance in a multiethnic group of 60 obese adolescents over the course of approximately 30 months. Each subject underwent three serial 3-h oral glucose tolerance tests. Dynamic, static, and total beta-cell responsivity (Phi(d), Phi(s), and Phi(tot), respectively) and S(i) were assessed by oral C-peptide and glucose minimal models. The disposition index (DI), which adjusts insulin secretion for S(i), was calculated. RESULTS: At baseline, all 60 subjects had NGT. Seventy-seven percent (46 subjects) maintained NGT over the three testing periods (nonprogressors), whereas 23% (14 subjects) developed IGT over time (progressors). At baseline, percent fat and BMI Z score were comparable between the groups. Fasting plasma glucose, 2-h glucose, glucose area under the curve at 180 min, and Phi(d) were significantly different between the two groups at baseline, whereas S(i) was comparable between the two groups. Over time, although S(i) remained unchanged in nonprogressors, it steadily worsened by approximately 45% (P > 0.04) in progressors. beta-Cell responsivity decreased by 20% in progressors, whereas it remained stable in nonprogressors. The DI showed a progressive decline in progressors compared with a modest improvement in nonprogressors (P = 0.02). CONCLUSIONS: Obese adolescents who progress to IGT may manifest primary defects in beta-cell function. In addition, progressive decline in S(i) further aggravates beta-cell function, contributing to the worsening of glucose intolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [37]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 1×
“RESEARCH DESIGN AND METHODS — The Yale Pathophysiology of Type 2 Diabetes in Obese Youth Study is a long-term project aimed at examining early alterations in glucose metabolism in obese children and adolescents (14,15).”
BackgroundSelf-citationKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Applied Mixed Models in Medicine
Brown, H., & Presco, R. (2000) · Technometrics · doi:10.1080/00401706.2000.10485742 · Cited by 1,262 · cited 1×
“Linear trajectories from repeated measures of outcomes over time were estimated by random effects regression (19).”
MethodFive stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Predictors of Changes in Glucose Tolerance Status in Obese Youth
Weiss, R., Taksali, S. E., Tamborlane, W. V., Burgert, T. S., Savoye, M., & Caprio, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.902 · Cited by 378 · cited 1×
“One longitudinal study in obese adolescents with IGT at baseline indicated that over a period of 23 months, 45% reverted to normal glucose tolerance (NGT), 30% maintained IGT, and 25% developed type 2 diabetes(11).”
BackgroundSelf-citationWeyer, C., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.89 · Cited by 357
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., Palmer, J. P., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.11.1663 · Cited by 328
Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity
Breda, E., Cavaghan, M. K., Toffolo, G., Polonsky, K. S., & Cobelli, C. (2001) · Diabetes · doi:10.2337/diabetes.50.1.150 · Cited by 320
Self-citation
Cited by
Diabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
“For instance, the battery of oral glucose, C-peptide, and insulin models have been used in studying: the effect of age and gender on glucose metabolism [59]; the effect of anti-aging drugs [110]; the influence of ethnicity [111]; insulin sensitivity and beta-cell function in nondiabetic [112] and obese [113] adolescen…”
Self-citationTaylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485
Insulin resistance in children: Consensus, perspective, and future directions
Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1047 · Cited by 405
Gujral, U. P., Pradeepa, R., Weber, M. B., Narayan, K. M. V., & Mohan, V. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06838.x · Cited by 398
The Triglyceride-to-HDL Cholesterol Ratio
Giannini, C., Santoro, N., Caprio, S., Kim, G., Lartaud, D., Shaw, M., Pierpont, B., & Weiss, R. (2011) · Diabetes Care · doi:10.2337/dc10-2234 · Cited by 360
Self-citationType 2 Diabetes in Youth: Epidemiology and Pathophysiology
D’Adamo, E., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc11-s212 · Cited by 315
Self-citationScholtens, D. M., Kuang, A., Lowe, L. P., Hamilton, J., Lawrence, J. M., Lebenthal, Y., Brickman, W. J., Clayton, P., Ma, R. C., McCance, D., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2021 · Cited by 310
Cardiometabolic risk in obese children
Chung, S. T., Onuzuruike, A. U., & Magge, S. N. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13602 · Cited by 213
Cobelli, C., Dalla Man, C., Toffolo, G., Basu, R., Vella, A., & Rizza, R. (2014) · Diabetes · doi:10.2337/db13-1198 · Cited by 216
Self-citationVilas‐Boas, E. A., de Almeida, D. C., Roma, L. P., Ortis, F., & Carpinelli, Â. R. (2021) · Cells · doi:10.3390/cells10123328 · Cited by 183
“only when pancreatic β-cell’s capacity is overwhelmed and insulin secretion fails—via either loss of β-cell function or mass (discussed later)—that overt hyperglycemia and T2D ensue [6,7].”
BackgroundPathophysiology of Type 2 Diabetes in Children and Adolescents
Valaiyapathi, B., Gower, B. A., & Ashraf, A. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180608074510 · Cited by 191
Pathophysiology of prediabetes
Abdul-Ghani, M. A., & DeFronzo, R. A. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0032-7 · Cited by 178
Giannini, C., Weiss, R., Cali, A., Bonadonna, R., Santoro, N., Pierpont, B., Shaw, M., & Caprio, S. (2012) · Diabetes · doi:10.2337/db11-1111 · Cited by 137
Self-citationEvidence of Reduced β-Cell Function in Asian Indians With Mild Dysglycemia
Staimez, L. R., Weber, M. B., Ranjani, H., Ali, M. K., Echouffo-Tcheugui, J. B., Phillips, L. S., Mohan, V., & Narayan, K. M. V. (2013) · Diabetes Care · doi:10.2337/dc12-2290 · Cited by 313
Altered Volume, Morphology and Composition of the Pancreas in Type 2 Diabetes
Macauley, M., Percival, K., Thelwall, P. E., Hollingsworth, K. G., & Taylor, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126825 · Cited by 119
“However, blood glucose levels do not rise unless pancreatic insulin secretory function has declined by approximately 50%, and the subsequent gradual deterioration of blood glucose control is related solely to declining beta cell competence [3–5].”
BackgroundManco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., Petrie, J. R., & Mingrone, G. (2010) · Diabetes Care · doi:10.2337/dc09-2261 · Cited by 120
Antoun, E., Kitaba, N. T., Titcombe, P., Dalrymple, K. V., Garratt, E. S., Barton, S. J., Murray, R. J. S., Seed, P. T., Holbrook, J. D., Kobor, M. S., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003229 · Cited by 114
Michaliszyn, S. F., Mari, A., Lee, S., Bacha, F., Tfayli, H., Farchoukh, L., Ferrannini, E., & Arslanian, S. (2014) · Diabetes · doi:10.2337/db13-1951 · Cited by 92
Hannon, T. S., Kahn, S. E., Utzschneider, K. M., Buchanan, T. A., Nadeau, K. J., Zeitler, P. S., Ehrmann, D. A., Arslanian, S. A., Caprio, S., Edelstein, S. L., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13005 · Cited by 87
Self-citationβ-Cell failure in type 2 diabetes
Leibowitz, G., Kaiser, N., & Cerasi, E. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00094.x · Cited by 78
Burns, S. F., Bacha, F., Lee, S. J., Tfayli, H., Gungor, N., & Arslanian, S. A. (2011) · Diabetes Care · doi:10.2337/dc11-0423 · Cited by 75
“Longitudinal data in obese adolescents progressing to IGT suggest that individuals with IGT manifest primary defects in b-cell function, which is aggravated by declining insulin sensitivity (6,7).”
BackgroundEtiology of insulin resistance in youth with type 2 diabetes
Cree-Green, M., Triolo, T. M., & Nadeau, K. J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0341-0 · Cited by 69
“In longitudinal pediatric population studies, IR worsens already damaged beta cells [29, 74], and cross sectional studies show that children who progress to T2DM have lower insulin levels [67].”
BackgroundThe β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
“Thus, for example, it has been reported that (i) insulin secretion rates are increased in obese individuals (554); (ii) β-cell function decreases progressively as glucose tolerance declines in adults (554) and youth (555-557); (iii) the response to bariatric surgery is dependent on β-cell function at baseline, with a…”
BackgroundPrediabetes in youths: mechanisms and biomarkers
Weiss, R., Santoro, N., Giannini, C., Galderisi, A., Umano, G. R., & Caprio, S. (2017) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(17)30044-5 · Cited by 63
Self-citationBeyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth
Nolfe, G., Spreghini, M. R., Sforza, R. W., Morino, G. S., & Manco, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0827 · Cited by 65
TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes
Shah, M., Varghese, R. T., Miles, J. M., Piccinini, F., Dalla Man, C., Cobelli, C., Bailey, K. R., Rizza, R. A., & Vella, A. (2016) · Diabetes · doi:10.2337/db15-1233 · Cited by 57
Self-citationInsulin-resistance in paediatric age: Its magnitude and implications
Al‐Beltagi, M., Bediwy, A. S., & Saeed, N. K. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i4.282 · Cited by 70
O’Malley, G., Santoro, N., Northrup, V. S., D’Adamo, E., Shaw, M. M., Eldrich, S., & Caprio, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1693-0 · Cited by 59
“Our group, using three serial OGTTs over a 3-year period in obese adolescents with normal glucose tolerance at baseline, observed remarkable stability in insulin sensitivity, beta cell function and DI [ 22 ].”
MethodSelf-citationMetabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
D’Adamo, E., Santoro, N., & Caprio, S. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.005 · Cited by 54
Self-citationStudy of beta-cell function (by HOMA model) in metabolic syndrome
Garg, M., Dutta, M., & Mahalle, N. P. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83059 · Cited by 53
Insulin Dynamics of Breast- or Formula-Fed Overweight and Obese Children
Manco, M., Alterio, A., Bugianesi, E., Ciampalini, P., Mariani, P., Finocchi, M., Agostoni, C. V., & Nobili, V. (2011) · Journal of the American College of Nutrition · doi:10.1080/07315724.2011.10719941 · Cited by 48
“The DI estimates the ability of the beta cell to compensate for increased insulin resistance [28].”
BackgroundInsulin and BMI as Predictors of Adult Type 2 Diabetes Mellitus
Sabin, M. A., Magnussen, C. G., Juonala, M., Hamilton-Shield, J. P., Kähönen, M. A. P., Lehtimäki, T. J., Rönnemaa, T., Koskinen, J. M., Loo, B.-M., Knip, M., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-1534 · Cited by 55
Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
D’Adamo, E., Santoro, N., & Caprio, S. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.06.002 · Cited by 61
Self-citationBervoets, L., & Massa, G. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0395 · Cited by 47
Sjaarda, L. A., Michaliszyn, S. F., Lee, S., Tfayli, H. M., Bacha, F. F., Farchoukh, L. O., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-0747 · Cited by 50
“In addition, we (12,13) and others (30,31) have reported progressively declining DI across the spectrum of glycemia from normal to IFG and/or IGT to type 2 diabetes in youth.”
BackgroundTranslating aetiological insight into sustainable management of type 2 diabetes
Taylor, R., & Barnes, A. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4504-z · Cited by 49
“Understanding what is happening in the pancreas is the key to type 2 diabetes, as the condition never occurs without a major decrease in acute insulin secretion [20, 21].”
BackgroundSerbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 46
Diabetes and Insulin Resistance in Pediatric Obesity
Kim, G. J., & Caprio, S. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.09.002 · Cited by 51
Self-citationGalderisi, A., Giannini, C., Name, M. A. V., & Caprio, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00161 · Cited by 41
Self-citationMethods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT)
Chen, M. E., Aguirre, R. S., & Hannon, T. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1023-3 · Cited by 42
Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
D’Adamo, E., Santoro, N., & Caprio, S. (2013) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2013.02.004 · Cited by 42
Self-citationGiannini, C., Man, C. D., Groop, L., Cobelli, C., Zhao, H., Shaw, M. M., Duran, E. J., Pierpont, B. M., Bale, A. E., Caprio, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1458 · Cited by 37
Self-citationDevelopment of Type 2 Diabetes Mellitus in the Obese Adolescent:A Growing Challenge
Caprio, S. (2012) · Endocrine Practice · doi:10.4158/ep12142.ra · Cited by 39
“Of note, adolescents who progressed to IGT had a lower b-cell function at baseline than did nonprogressors, as indicated by the glucose b-cell responsiveness (Φd), measured by the oral minimal model (18).”
BackgroundMethodSelf-citationHyperprolactinemia and insulin resistance
Gierach, M., Bruska-Sikorska, M., Rojek, M., & Junik, R. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0075 · Cited by 36
Update on Nonautoimmune Diabetes in Children
Zeitler, P. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0493 · Cited by 34
Insulin resistance in type 2 diabetic youth
Mizokami‐Stout, K., Cree‐Green, M., & Nadeau, K. J. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283557cd5 · Cited by 35
“Studies evaluating tissue-specific insulin resistance and secretion in obese adolescents across the spectrum of glucose tolerance showed increased peripheral insulin resistance in IGT and combined IFG/IGT, whereas hepatic insulin resistance was increased in IGT, IFG, IFG/IGT and T2DM [27,42,43].”
BackgroundResultMeasuring β-Cell Function Relative to Insulin Sensitivity in Youth
Sjaarda, L. A., Lee, S., Tfayli, H. M., Bacha, F. F., Bertolet, M. H., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-1508 · Cited by 37
“We (4,22) and others (32,33) have reported that DI decreases progressively across the spectrum of deteriorating glycemia in youth.”
BackgroundQuantifying beta cell function in the preclinical stages of type 1 diabetes
Galderisi, A., Carr, A. L. J., Martino, M., Taylor, P., Senior, P. A., & Dayan, C. M. (2023) · Diabetologia · doi:10.1007/s00125-023-06011-5 · Cited by 33
“…insulin and C-peptide kinetics have been proposed [12, 35, 81, 82], here we focus on Cobelli’s oral minimal model [83] and Mari’s model [82] because of their large validation in different age groups, including paediatric cohorts [5, 84], and wide use over the last few decades [35, 79, 81, 84, 85].”
MethodCochran, B. J., Hou, L., Manavalan, A. P. C., Moore, B. M., Tabet, F., Sultana, A., Torres, L. C., Tang, S., Shrestha, S., Senanayake, P., et al. (2016) · Diabetes · doi:10.2337/db16-0668 · Cited by 30
Chandler-Laney, P. C., Schneider, C. R., Gower, B. A., Granger, W. M., Mancuso, M., & Biggio, J. (2015) · Maternal and Child Nutrition · doi:10.1111/mcn.12181 · Cited by 30
“Previous research suggests that this initial deficit in glucose-stimulated insulin secretion may be part of the aetiology for type 2 diabetes (Cali et al. 2009).”
1-Hour plasma glucose in obese youth
Manco, M., del Giudice, E. M., Spreghini, M. R., Cappa, M., Perrone, L., Brufani, C., Rustico, C., Morino, G. S., & Caprio, S. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0384-3 · Cited by 27
“More recently, in the same cohort [22], NGT individuals who progressed to IGT (14%, N = 14) over 30-months follow-up had the same BMI z-score and percent fat mass, but higher glucose under the curve, plasma glucose concentration in fasting condition and at 120 min following the OGTT than NGT individuals who did not pr…”
BackgroundResultSelf-citationChen, M. E., Chandramouli, A. G., Considine, R. V., Hannon, T. S., & Mather, K. J. (2018) · Diabetes Care · doi:10.2337/dc17-1373 · Cited by 26
“NGT to IGT compared with nonprogressors, in addition to a 20% reduction of insulin secretion in progressors (26).”
BackgroundMethodGalderisi, A., Moran, A., Evans‐Molina, C., Martino, M., Santoro, N., Caprio, S., & Cobelli, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab344 · Cited by 28
Self-citationYeow, T. P., Pacini, G., Tura, A., Hor, C. P., Lim, S. L., Tan, F. H. S., Tong, C. V., Hong, J. Y. H., Zain, F. M., Holst, J. J., et al. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000352 · Cited by 26
Metabolic Syndrome in Pediatrics
Kursawe, R., & Santoro, N. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800141-7.00004-8 · Cited by 25
Calorie restriction and reversal of type 2 diabetes
Taylor, R. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1239525 · Cited by 25
“In obese young people, decreased β-cell function predicts deterioration of glucose tolerance [75,76].”
BackgroundCobelli, C., & Man, C. D. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211015268 · Cited by 24
Self-citationβ-Cell Dysfunction in Adolescents and Adults with Newly Diagnosed Type 2 Diabetes Mellitus
Elder, D. A., Herbers, P. M., Weis, T., Standiford, D. A., Woo, J. G., & D’Alessio, D. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.002 · Cited by 25
Islet function in obese adolescents
Giannini, C., & Caprio, S. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01643.x · Cited by 24
“The role of ‘pre-existing’ β-cell dysfunction risk in obese adolescents with normal glucose tolerance was subsequently revealed by Cali et al. in a longitudinal study in which β-cell function was assessed from OGTT using the Oral C-Peptide Minimal Model [16].”
MethodSelf-citationAlizadeh, M., Taghizadeh, S., & Kheirouri, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.028 · Cited by 18
Sabolić, L. L. G., Šepec, M. P., Berković, M. C., & Stipančić, G. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0142 · Cited by 14
Type 2 diabetes mellitus in pediatrics: a new challenge
Name, M. A. V., & Santoro, N. (2013) · World Journal of Pediatrics · doi:10.1007/s12519-013-0438-9 · Cited by 18
Hou, X., Chen, P., Hu, G., Wei, L., Jiao, L., Wang, H., Liang, Y., Bao, Y., & Jia, W. (2018) · Obesity · doi:10.1002/oby.22183 · Cited by 16
Bartlette, K., Carreau, A., Xie, D., Garcia‐Reyes, Y., Rahat, H., Pyle, L. L., Nadeau, K. J., Cree‐Green, M., & Behn, C. D. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100078 · Cited by 15
Galderisi, A., Evans‐Molina, C., Martino, M., Caprio, S., Cobelli, C., & Moran, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac740 · Cited by 13
Self-citationLongitudinal association between adiposity measures and regression of prediabetes/diabetes
Modi, A., Gadhavi, R., Pérez, C. M., & JOSHIPURA, K. J. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.07.005 · Cited by 13
The Oral Disposition Index: A Valuable Estimate of β-Cell Function in Obese Youth
Caprio, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.02.013 · Cited by 12
Self-citationUtzschneider, K., Johnson, T. N., Breymeyer, K. L., Bettcher, L. F., Raftery, D., Newton, K., & Neuhouser, M. (2020) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2020.107586 · Cited by 9
Carreau, A., Xie, D., Garcia‐Reyes, Y., Rahat, H., Bartlette, K., Behn, C. D., Pyle, L. L., Nadeau, K. J., & Cree‐Green, M. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13072 · Cited by 13
Hosking, J., Metcalf, B. S., Jeffery, A., Streeter, A., Voss, L. D., & Wilkin, T. J. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12049 · Cited by 12
“impaired beta-cell function at baseline (28, 29) and findings from the Bogalusa Heart study suggest a”
BackgroundProgression of β-Cell Dysfunction in Obese Youth
Giannini, C., & Caprio, S. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0347-7 · Cited by 15
“Results showed that compared with those who did not progress, obese adolescents who progressed to IGT had lower β-cell function at baseline [29].”
MethodResultSelf-citationSlusher, A. L., Hu, P., Samuels, S. L., Tokoglu, F., Lat, J., Li, Z., ALGUARD, M. D., Strober, J. W., Vatner, D. F., Shabanova, V., et al. (2023) · Obesity · doi:10.1002/oby.23728 · Cited by 11
“using MRI-derived hepatic fat fraction in youth with obesity found that intrahepatic triglyceride content equal to or greater than 10% was inversely correlated with insulin sensitivity and β-cell function [11].”
MethodSelf-citationAssaf, J., Khurana, I., Zaki, R. A., Tam, C. H. T., Correa, I. S., Maxwell, S., Kinnberg, J., Christiansen, M., Frørup, C., Lee, H. M., et al. (2025) · Diabetes · doi:10.2337/db25-0105 · Cited by 9
Lin, Z., Zhou, J., Li, X., Song, L., Hou, X., Tang, J., Wang, C., & Jia, W. (2014) · Endocrine · doi:10.1007/s12020-014-0244-8 · Cited by 8
“Both basic and population studies have proved that defects of first-phase or early insulin secretion is an important inherent characteristic in type 2 diabetes [33–36].”
BackgroundEnders-Seidlitz, H., Raile, K., Gong, M., Galler, A., Kuehnen, P., & Wiegand, S. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5558634 · Cited by 8
“Even before the onset of T2D, children and adolescents show reduced insulin secretion [39].”
BackgroundGuzmán-García, J.-M., Romero‐Saldaña, M., Molina‐Recio, G., del Pozo, F. J. F., Raya-Cano, E., & Molina‐Luque, R. (2023) · Pediatric Research · doi:10.1038/s41390-023-02693-0 · Cited by 7
Insulin Sensitivity from Preschool to School Age in Patients with Severe Obesity
Manco, M., Spreghini, M. R., Luciano, R., Pensini, C., Sforza, R. W., Rustico, C., Cappa, M., & Morino, G. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068628 · Cited by 7
Yazel-Smith, L. G., Pike, J. M., Lynch, D., Moore, C. M., Haberlin-Pittz, K. M., Taylor, J. D., & Hannon, T. S. (2018) · Health Promotion Practice · doi:10.1177/1524839918778555 · Cited by 8
Harnois‐Leblanc, S., Hulst, A. V., Ybarra, M., Barnett, T. A., Mathieu, M.-E., McGrath, J. J., Tremblay, A., Paradis, G., Drapeau, V., Sylvestre, M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13315 · Cited by 7
“was stable among children who remained NGT, and gradually decreased in those children who deteriorated to IGT.(6) In the present study, among children with complete glucose data at the 3-time points, beta-cell function slightly decreased between 10–12 and 15–17 years in the “reverters” and “maintainers”, while it decl…”
BackgroundInfluentialPatel, Y. R., Kirkman, M. S., Considine, R. V., Hannon, T. S., & Mather, K. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2056 · Cited by 7
Comparing Simple Insulin Sensitivity Indices to the Oral Minimal Model Postexercise
Rynders, C. A., Weltman, J. Y., Malin, S. K., Jiang, B., Breton, M. D., Barrett, E. J., & WELTMAN, A. L. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000728 · Cited by 7
Ciresi, A., & Giordano, C. S. D. S. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0805-9 · Cited by 7
Geragotou, T., Jainandunsing, S., Özcan, B., de Rooij, F. W. M., Kokkinos, A. D., Tentolouris, N., & Sijbrands, E. J. G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/9286303 · Cited by 7
“Resistance to insulin is characteristic of metabolic syndrome (MetS), which is defined as a cluster of the following cardiovascular risk factors: central obesity, impaired glucose tolerance, dyslipidemia, and hypertension.”
BackgroundUse of a simple liquid meal test to evaluate insulin sensitivity and beta‐cell function in children
Chandler-Laney, P. C., Higgins, P. B., Granger, W. M., Alvarez, J. A., Casazza, K., Fernández, J. R., Man, C. D., Cobelli, C., & Gower, B. A. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00147.x · Cited by 5
“Furthermore, the oral glucose test has been shown to be a useful predictor of conversion to type 2 diabetes among obese adolescents (18).”
BackgroundSelf-citationAssociation with insulin resistance in obese youths of different ethnic backgrounds
Giannini, C., Santoro, N., Caprio, S., Kim, G. E., Lartaud, D., Shaw, M. M., Pierpont, B. M., & Weiss, R. (2011) · Cited by 6
Self-citationSuárez, R. M. G., Amador, P., & Calzado, C. M. A. (2010) · Revista cubana de endocrinología · Cited by 13
Inside out the Ragbag of Glucose Intolerance in Obese Adolescents
Brufani, C., Tura, A., Bedogni, G., Luciano, R., Sbrignadello, S., Fintini, D., Cappa, M., Weiss, R., & Manco, M. (2017) · Hormone Research in Paediatrics · doi:10.1159/000464144 · Cited by 5
Li, G., Chen, X., Liang, X., Hu, L., Zhang, L., Xu, X., Wu, W., Huang, K., Dong, G., Zhang, J., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12905 · Cited by 4
Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., Cali, A. M. G., & Caprio, S. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_13 · Cited by 5
Self-citationThe role of childhood BMI in predicting early adulthood dysglycemia: Tehran lipid and glucose study
Piri, Z. A., Barzin, M., Mahdavi, M., Guity, K., Azizi, F., Hosseinpanah, F., & Valizadeh, M. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.026 · Cited by 4
Anwar, M. K., Hussain, M. M., Khan, M. A., & Ahmad, T. (2013) · PubMed · Cited by 6
Beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes
Zelada, H., Carnero, A. M., Hurtado, C. J. M., Aliaga, D. I. C., Munarriz, C. A. L., Aro, P., & Manrique, H. A. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.05.003 · Cited by 6
Vogt, J. A., Domzig, C., Wabitsch, M., & Denzer, C. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00455.2014 · Cited by 6
Camilo, D. F., Vasques, A. C. J., Hayashi, K., Tura, A., da Silva, C. D. C., Zambon, M. P., Antonio, M. Â. R. D. G. M., & Geloneze, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.013 · Cited by 3
Hagman, E. (2016) · Figshare · Cited by 5
Whole-Body and Cellular Models of Glucose-Stimulated Insulin Secretion
TOFFOLO, G. M., Pedersen, M. G., & Cobelli, C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_22 · Cited by 2
Self-citationThe emerging landscape of childhood diabetes: unraveling the diagnosis
Amed, S., & Hamilton, J. K. (2012) · Diabetes Management · doi:10.2217/dmt.12.65 · Cited by 1
Pinhas‐Hamiel, O., & Zeitler, P. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374995-6.10008-8 · Cited by 1
Țaranu, I., Bolboaca, S. D., & Creț, V. (2020) · Folia Medica · doi:10.3897/folmed.62.e51120 · Cited by 1
Type II Diabetes Mellitus and Obesity in Youths
Giannini, C., & Caprio, S. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_29 · Cited by 1
Self-citation
Metadata
- Authors
- Cali, A. M. G., Man, C. D., Cobelli, C., Dziura, J., Seyal, A., Shaw, M., Allen, K., Chen, S., & Caprio, S.
- Affiliations
- Yale University (US)
- University of Padua (IT)
- Corresponding author
- Caprio, Sonia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-03-01
- Volume
- 32
- Issue
- 3
- Pages
- 456-461
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2646028
- OpenAlex
- W2143243643
- Cited by
- 125
- References
- 26
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 10 · 2015: 6 · 2014: 7 · 2013: 14 · 2012: 16
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- National Institutes of Health (and K24)
- National Center for Research Resources (UL1 RR0249139)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD- 28016, R01HD028016, R01-HD40787, K24HD001464, R01HD040787, K24-HD01464)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- impaired glucose tolerance, adolescent obesity, beta-cell function, insulin resistance, insulin sensitivity, disposition index, prediabetes progression, oral glucose tolerance test, C-peptide, natural history (disease)
- MeSH terms
- Adolescent, Child, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Male, Obesity, Glucose Intolerance, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
